MeSH D011565 - psoriasis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| A.H. Robins Company | Cortisone | Cortisone |  | 1982-01-01 |  |  |
| AbbVie | Calcitriol | Calcijex |  | 1986-09-25 |  |  |
| Cyclosporine | Cyclosporine |  | 2000-03-03 |  |  | |
| Cyclosporine | Gengraf |  | 2000-05-12 |  |  | |
| Adalimumab | Humira |  | 2003-09-08 | $13,133 M | Q2/23-Q1/24 | |
| Risankizumab | Skyrizi |  | 2019-04-23 | $8,411 M | Q2/23-Q1/24 | |
| Cyclosporine | Restasis Multidose | 2024-08-27 | 2002-12-23 |  |  | |
| Accord Healthcare | Mycophenolate mofetil | Mycophenolate Mofetil |  | 2009-05-04 |  |  |
| Mycophenolic acid | Mycophenolic |  | 2017-08-23 |  |  | |
| Methotrexate | Methotrexate |  | 2007-04-30 |  |  | |
| Alimera Sciences | Fluocinolone acetonide | Iluvien | 2027-08-12 | 2014-09-26 |  |  |
| Fluocinolone acetonide | Yutiq | 2027-08-12 | 2018-10-12 |  |  | |
| Alkem Laboratories | Mycophenolate mofetil | Mycophenolate Mofetil |  | 2011-11-04 |  |  |
| Mycophenolic acid | Mycophenolic |  | 2021-09-23 |  |  | |
| Allergan | Tazarotene | Avage |  | 2000-09-29 |  |  |
| Fluocinolone acetonide | Fluonid |  | 1984-09-06 |  |  | |
| Tazarotene | Tazorac |  | 1997-06-13 |  |  | |
| Betamethasone | Betamethasone |  | 1984-10-10 |  |  | |
| Clotrimazole, Betamethasone | Clotrimazole Betamethasone |  | 2002-08-02 |  |  | |
| Cortisone | Cortisone |  | 1982-01-01 |  |  | |
| Fluocinolone acetonide | Fluocinolone |  | 2016-10-21 |  |  | |
| Betamethasone | Valnac |  | 1984-10-10 |  |  | |
| Almirall | Tildrakizumab | Ilumetri |  | 2018-09-17 |  |  |
| Dimethyl fumarate | Skilarence |  | 2017-06-23 |  |  | |
| Alpharma | Betamethasone | Betamethasone |  | 1987-02-03 |  |  |
| Fluocinolone acetonide | Fluocet |  | 1984-01-16 |  |  | |
| Fluocinolone acetonide | Fluocinolone |  | 1982-06-16 |  |  | |
| American Regent | Betamethasone | Betamethasone Betamethasone |  | 2009-07-31 |  |  |
| Calcitriol | Calcitriol |  | 2003-09-26 |  |  | |
| Amgen | Adalimumab | Amgevita |  | 2017-03-21 |  |  |
| Apremilast | Otezla |  | 2015-01-15 | $2,190 M | Q2/23-Q1/24 | |
| Adalimumab | Solymbic |  | 2017-03-22 |  |  |
1
2
3
4
5
6
...
13
>
Clinical Trials
Historical Success Rate
Phase 1
56%49/87
Phase 2
46%49/107
Phase 3
76%69/91
Approved: 37Overall Success rate: 20%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
9
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use